IRMA TRUpoint Creatinine Cartridge Field Launch

Slides:



Advertisements
Similar presentations
Evaluation of Oral Azacitidine Using Extended Treatment Schedules: A Phase I Study Garcia-Manero G et al. Proc ASH 2010;Abstract 603.
Advertisements

AKI in Pediatrics Patrick D. Brophy MD Associate Professor
Managing Sick Days and Hospital Stays Mike Heile MD Orlando, CWD July, 2011.
DIABETES MANAGEMENT 2006: INTEGRATING NEW MEDICINES AND NEW DEVICES
Using Wireless Technology and the Internet to Improve Patient Outcomes.
NEX in treatment services 8 August The guidance Ensure services offering opioid substitution therapy also make needle and syringes available to.
Blood Transfusions. By Hayley & Pete.. Blood Transfusions. Blood transfusion is the process of transferring blood or blood-based products from one person.
Girish Singhania N Engl J Med 2012 Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome.
Prevention of Contrast-Induced Nephropathy (CIN) Sepehr Khashaei, MD Assistant professor Department of Internal Medicine.
Patient Education & Assessment RTEC 93 Venipuncture.
1 Type 1 Diabetes Mellitus Treatment. 2 Goals of T1DM Management Utilize intensive therapy aimed at near-normal BG and A1C levels Prevent diabetic ketoacidosis.
Dietary Approach To C Kidney Disease
Nallasamy K, Jayashree M, Singhi S, Bansal A
Journal Club Rakesh Latchamsetty October 5, 2007.
Renal Megan McClintock, RN, MS 10/27/11 “TO PEE IS TO LIVE”
Renal Protection for Coronary Angiography in Advanced Renal Failure Patients by Prophylactic Hemodialysis Presented by Mike Touchy, HO-I.
REMEDIAL II Renal Insufficiency Following Contrast Media Administration Trial II (REMEDIAL II): RenalGuard™ System In High-Risk Patients for Contrast-Induced.
Natale MARRAZZO Francesco SOLIMENE Quando la CRT-P può bastare?
 Contrast media is a substance utilized to aid in the visualization of structures and vessels not seen under normal medical imaging.  Comes in the form.
+ Acute Kidney Injury Clinical Directors Forum March 2010 Mark Brady Clinical Advisor, Department of Health.
PLC’s Growth Initiative: Renal Guard May 7, 2007.
3. The ASCERTAIN Study. Source Holdaas H, Rostaing L, Serón D, et al. Conversion of long-term kidney transplant recipients from calcineurin inhibitor.
Blood Glucose Monitoring And Bloodborne Pathogens
Journal Club Usha Niranjan PICU. Rationale 2 x cases of severe dehydration with metabolic acidosis –requesting for HDU management –as given 40mls/kg fluid.
Buffer Solutions May Compromise Cardiac Resuscitation by Reducing Coronary Perfusion Pressure JAMA. 1991;226: Kette, Weil, Gazmuri Chicago, IL.
Computer-Assisted Decision Making in the Twenty-First Century James J. Cimino, M.D. Departments of Medical Informatics and Medicine Columbia University.
Can we prevent myocardial and renal revascularization injury? Preventive effect of trimetazidine MR on myocardial and renal injury in diabetic patients.
Standard Treatment Protocols Managing Quality & Cost Dr. Farouk Abdallah Pediatrician, Q.M. Consultant Esqua Founder & Board Member 1995 Nasser Institute.
The EINSTEIN DVT Study 'Xarelto' for the Acute and Continued Treatment of Symptomatic Deep Vein Thrombosis.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
New Treatment Opportunity: Valganciclovir
臨床藥事照護 年 09 月其他之用藥建議 疑問藥物問題內容後續追蹤 Actein qid 2 包非正常使用 dose FOR CKD 病人的腎臟 保護 2 文獻資料資料來源 Prophylactic oral administration of the antioxidant.
The level of evidence utilized to answer general practitioners’ questions Karen Davies.
Radiocontrast Nephropathy Jason S. Finkelstein, M.D. Tulane University HSC Division of Cardiology 3/2/04.
Rapid Containment: Pharmaceutical Measures (Phase 4 & 5)
MRI Safety Course Module 2- Emergency Situations.
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study) Lambers Heerspink,
Sandeep Bagla, MD Cardiovascular & Interventional Radiology Inova Alexandria Hospital.
Bioterrorism Drill Case 4 Plague: Responder Roles.
Sharps injuries among radiographers: Dangers associated with opening bottles of contrast agent Professor Gill Marshall Chair of Medical Imaging Education.
Introducation to Critical Care Nursing
Toujeo® and it’s Place in Therapy
Community Acquired Pneumonia in the Emergency Department (ED) Emergency Department Nurses & Physicians Dr. Mark Cichon, Director; Bridget Gaughan, Manager.
Major Clinical Trials in AKI Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre.
Bicarbonate-Based Solutions in the Management of Acute Kidney Injury Vania Cecilia Prudencio-Ribera, MD 1 ; Universidad Mayor de San Simón, School of Medicine,
Critical Appraisal of an Article on HARM. Clinical Question Is there potential harm after administering allopurinol in patients with gout and azotemia?
Conclusions. Conclusions -In patients undergoing primary angioplasty, prophylactic treatment with N-acetylcysteine seems to reduce the rate of contrast-medium.
Gynaecology MDT Coordinator
HARM APPRAISAL. Is the objective of the article on harm similar to your clinical dilemma?
Hexabrix Key Clinical Review Liss, 2006 Mid-Year Sales Meeting Bloomington, IN July 13 th – 17 th.
Central Carolina Perfusion
Platelet Transfusions Indications, dose and administration
CR-1 Candesartan in HF Benefit/Risk James B. Young, MD Cleveland Clinic Foundation.
A.Rasoolzadeh MD. Contrast induced nephropathy (CIN): A kind of reversible AKI as a rise in serum creatinine (by 25%) during of h after receipt.
Diabetes and the Kidney Richard Kingston Department of Renal Medicine Kent and Canterbury Hospital.
Quality Management in the ICU Mazen Kherallah, MD, FCCP Chairman, Critical Care Department King Faisal Specialist Hospital & Research Center.
Status Epilepticus Presenting After Traumatic Brain Injury in Infants Kurz, J. E.1; Zelleke, T.1; Carpenter, J.1; Dean, N.2; Singh, J.1; Kadom, N.3; Gaillard,
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
Emergency Severity Index Triage Training
Senior Medical Director, Cardiovascular
Clinical Cases in Glaucoma Treatment
Wednesday 7 June – Tuesday 13 June
Section 4: Contrast-induced AKI
Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Patient engagement with digital therapeutic leads to reduction of A1C and costs in T2DM patients: Cost savings are correlated to both A1C drops as well.
AEROSET® & ARCHITECT® c8000® OEM Reagent Training
ARCHITECT cSystems OEM Reagent Training
Section 4: Contrast-induced AKI
Dr Donal O’Donoghue National Clinical Director for Kidney Care
Presentation transcript:

IRMA TRUpoint Creatinine Cartridge Field Launch

Business Confidential Product Description The IRMA TRUpoint Creatinine (CR) Cartridge is a point-of-care test for the direct measurement of creatinine in whole blood. Each CR Cartridge is pre-packaged with a liquid calibrant in the luer cap. Similar to the Glucose and H4 calibration cap. February 9, 2006 Business Confidential

CR Cartridge Specifications Methodology: Enzymatic reaction (Substrate Specific Electrode) Typical Precision (Blood): Level 1 Level 2 Mean: 1.5 8.2 SD: 0.09 0.46 %CV 6.1% 5.6% Range 0.2 - 12 mg/dL Shelf life: Maximum: 8 weeks Average international dating: (4-7 weeks) Storage: Shipped overnight with cool packs, pre-cleared thru customs Requires refrigeration (2-8) upon arrival February 9, 2006 Business Confidential

Business Confidential Creatinine Controls 6 syringes per box 3 – Level 1 3 – Level 2 1.5 mL LQC per syringe Refrigerate (2 - 8 C) Shelf life: Maximum - 3 months Average international field dating: 5-10 weeks February 9, 2006 Business Confidential

Business Confidential Why Test Creatinine? More than 10% of hospital-acquired renal failure is contrast-media induced.1 Contrast induced renal failure (nephropathy) is a common complication of radiographic procedures. Elimination of contrast media in renal compromised patients is prolonged. This leads to longer exposure of the kidneys to contrast agents. G. Merten, MD; et al. Prevention of Contrast-Induced Nephropathy with Sodium Bicarbonate. JAMA.2004;291;2328-2334. February 9, 2006 Business Confidential

Business Confidential Why Test Creatinine? To minimize risk of nephropathy many hospitals: Prescreen patients Perform a creatinine test Administer prophylactic treatment February 9, 2006 Business Confidential

Why Test Creatinine at the POC? Obtain immediate results at the bedside Intercede in therapy sooner Potentially improve patient throughput and satisfaction Potentially reduce hospital costs February 9, 2006 Business Confidential

CR Cartridge Value Proposition The IRMA TRUpoint Creatinine Cartridge provides timely results which can enable earlier interventions resulting in improved patient care, utilization of resources and patient triage. February 9, 2006 Business Confidential

Business Confidential Target Market ED or Radiology Department: Clinical decision making for injecting contrast during radiological procedures Critical in low end (<2 mg/dL ) due to potential for ATN- Acute Tubular Necrosis Diagnostic and Interventional Catheterization Lab Oncology Units Potentially anywhere that contrast media is administered. February 9, 2006 Business Confidential

IRMA TRUpoint Performance Clinical trials were held at 3 US sites, the following were observations from these studies: IRMA TRUpoint had: Excellent agreement with reference methodologies Intra-lot consistency Was clinically acceptable and met requirements for a POC device. The IRMA TRUpoint Creatinine showed 80-99% clinical agreement vs other methodologies. i-STAT, VITROS, Beckman, Jaffe Creatinine, Enzymatic Creatinine February 9, 2006 Business Confidential

Business Confidential Performance-Betas Data from Betas comparing IRMA to other methods Excellent correlation to reference method Customer correlation features makes it even better February 9, 2006 Business Confidential

Business Confidential Competition Laboratory Chemistry Analyzers (Many manufacturers) VITROS, Beckman, Abbott, Olympus, Hitachi most common Systems have different methodologies Jaffe Kinetic Jaffe Rate Blank Jaffe Substrate Specific Electrode (SSE) Near Patient Nova Bedside i-STAT February 9, 2006 Business Confidential

Competition-Key Differences i-STAT Calibration after sample is added Sample port is open/biohazards Instrument is not self contained No print out or direct download capabilities Interferences Lack of custom correlation factor NOVA High acquisition cost for a dedicated unit Maintenance associated with bench tops May have issues with high CV’s CAP surveys February 9, 2006 Business Confidential

Comparison ITC vs i-STAT i-STAT and ITC dating is similar While i-STAT may have some advantages with test time and storage, the beta sites indicated that ITC’s performance was superior! Additionally, IRMA TRUpoint has the custom correlation feature which enables correlation to the laboratory reference method. February 9, 2006 Business Confidential

Competitive Differences i-STAT lists the following as creatinine assay interferences: Sarcosine N-acetylcysteine These drugs have been tested and found NOT to effect on the IRMA TRUpoint creatinine assay. N-Acetylcysteine is administered to patients who require imaging contrast media and who have borderline renal function. Binds the contrast material to inhibit the nephrotoxicity. February 9, 2006 Business Confidential

Creatinine Product Additions The following are new product additions to the IRMA TRUpoint price list: Product Creatinine Cartridge Creatinine Controls Creatinine AMR Solution (linearity solution) IRMA TRUpoint Creatinine Ready Units Creatinine Upgrade February 9, 2006 Business Confidential

IRMA Creatinine Product Codes February 9, 2006 Business Confidential

Business Confidential Sales Brochure February 9, 2006 Business Confidential

Creatinine Cartridge Procedure 1 2 3 4 Insert cartridge When instructed, press Cal cap to dispense calibration solution Remove finger After successful calibration, remove Cal cap and inject sample February 9, 2006 Business Confidential

Temperature Requirements Storage Refrigerate upon arrival (2-8C) Not shipped refrigerated Remove from refrigerator prior to use 15 minutes to 8 hours Use within 15 minutes of opening package If removed from refrigerator for 8 hours and not used, discard, do not re-refrigerate February 9, 2006 Business Confidential

Business Confidential Implementation Linearity Kit Troubleshooting Hardware/Software Other cartridge changes February 9, 2006 Business Confidential

Business Confidential Linearity Analytical Measurement Range Testing ITC Creatinine AMR kit and protocol 3 mL vial of 500 mg/dL creatinine spiking solution Product Code 083000 Instructions provided with bottle CMS (CLIA) and CAP requirements Implementation Every 6 month February 9, 2006 Business Confidential

Troubleshooting Erroneous Results High Air bubble Insufficient sample volume Issues causing an abnormally low Hct Low Clot within sample Issues causing an abnormally high Hct February 9, 2006 Business Confidential

Creatinine Edge Connector New “Creatinine” edge connector required for all Creatinine customers. Creatinine edge connector labeling on the interior upper side of the edge connector. Cr edge connector must be matched with new hardware (board) and new v 6.2 software for compatibility. Not backward compatible. February 9, 2006 Business Confidential

Temperature Card Non-Creatinine Temperature Card P/N 432001 February 9, 2006 Business Confidential

Business Confidential Software Information New units will have IRMA 6.2 Software Customers upgrading units: Results and settings do not transfer Lose all your settings. Use DeviceSet 1.2.3, product code 464218 to save settings and restore them. February 9, 2006 Business Confidential

Business Confidential ITC Field Upgrade Form Completed Upgrade Form and sign Send to customer service with po. Form must be received by Customer Services before RMA is issued. February 9, 2006 Business Confidential

Business Confidential To be discussed/added Upgrade program process Riming Forms Promotions???? Pull/leverage into current capital promo Expectations/managing inventory with refrigeration February 9, 2006 Business Confidential